Research programme: triptycene analogues
Alternative Names: Triptycenes - research programmeLatest Information Update: 26 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action DNA synthesis inhibitors; Nucleoside transport protein inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 08 Nov 1999 New profile
- 08 Nov 1999 Preclinical development for Cancer in USA (Unknown route)